A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2018
At a glance
- Drugs Tocilizumab (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Acronyms TCZALS-001
- 09 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jul 2018.
- 09 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Aug 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.